Anagrelide Cancer Patent For Australia
Filed with ASX · · 2 pages · English
Arovella Therapeutics Limited on 6ix
Story so far
Earlier from Arovella Therapeutics
- Appendix 4C - quarterly
- TGA Approval Granted For ZolpiMist
- Prospectus For Entitlement Offer
- Entitlement Offer To Raise Approximately $3.56 Million
- Market Update
Later from Arovella Therapeutics
- Investor Presentation November 2020
- R & D Tax Incentive refund received
- AGM FY20 Presentation
- AGM FY20 Chairmans address and virtual meeting guide
- Placement Offer to raise $2.76m
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics